Emerging Therapeutic Company Investment, By the Numbers

2:00 PM - 2:45 PM (EDT), Monday, June 14, 2021
David Thomas, BIO’s Vice President of Industry Analysis, will provide an overview of new investment and deal trends for emerging therapeutic companies. Join this must-attend session for the latest data on licensing, M&A, venture capital, IPOs, follow-on public offerings, the therapeutic pipeline, FDA approvals, and drug development success rates.
Vice President, Industry Research
Biotechnology Innovation Organization